代谢综合征与勃起功能障碍发生相关性探讨

来源 :华夏医学论坛·泌尿生殖2015暨亚太性医学年会2015 | 被引量 : 0次 | 上传用户:snake_9655
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:近年来勃起功能障碍与代谢综合征的关系逐渐成为研究热点,但对此的国内的专题研究及报道还多限于综述,本实验研究结合各项指标对代谢综合征与大鼠勃起功能障碍发生的相关性进行探讨,为今后代谢综合征源性勃起功能障碍的诊断和治疗提供依据参考.
其他文献
目的:研究一组金黄色葡萄球菌侵袭性感染分离株的毒力基因存在状况,为临床治疗提供参考依据。方法:收集杭州市余杭区中医院2013年2至7月20株金黄色葡萄球菌侵袭性感染临床分离株,采用聚合酶链反应(PCR)的方法,分析16种黏附毒素、10种细胞毒素、9种侵袭性酶、20种超抗原、37种外毒素和2种荚膜抗原共计六大类94种毒力基因;并对毒力基因检测结果作菌株系统发育分析。结果:20株金黄色葡萄球菌侵袭性感
会议
Background: The quality of laboratory tests has a great impact on diagnosis and patient safety.Various lines of evidence show that pre-analytical errors are the major source of mistakes in the total t
会议
目的:检测miR-182、miR-196a在膀胱癌(BCa)组织中的表达水平,探讨miR-182、miR-196a及miR-182/miR-196a比值在BCa诊断、病理分级、临床分期中的意义。方法:选择67例膀胱移行细胞癌(TCCB)组织和34例正常膀胱黏膜(NBE)组织,利用临床常规HE染色进行膀胱癌组织病理分级确认,其病理Ⅰ、Ⅱ和Ⅲ级患者分别为31、24和12例,利用Wiley-Liss(2
会议
目的:探讨良性前列腺增生(BPH)合并腹股沟疝的一期微创手术方法.方法:2000年1月至2014年12月收治BPH合并腹股沟疝95例,均采用一期微创无张力疝修补术及经尿道等离子体双极电切(PKVP)治疗.结果:无手术死亡、大出血、切口感染及经尿道电切综合征(TURS)等.术后住院5~9 d,平均6d.
会议
Objective: Von Hippel-Lindau(VHL)disease is a rare autosomal dominant cancer syndrome.A phenomenon known as genetic anticipation has been documented in some hereditary cancer syndromes,where it was pr
Objective: This study aims to investigate the feasibility and mechanism of adipose-derived stem cells(ADSCs)-based micro-tissues(MTs)in the treatment of ED in a rat model of bilateral cavernous nerves
Objective: To investigate the status miR-155 and its targeting eNOS under the stimulation of glucose and ageBSA and to explore the effect of icariside Ⅱ(ICA Ⅱ)on the diabetic endothelial dysfunction o
Objective: This study aimed to explore the therapeutic effects of adipose-derived stem cells(ADSCs)-based microtissues(MTs)on erectile dysfunction(ED)in streptozotocin(STZ)induced diabetic rats.Method
Objective: Using adipose-derived stem cells(ADSCs)to halt stress urinary incontinence(SUI)progression and regenerate urethral sphincter(US)has emerged as a promising method to restore normal voiding f
Objective: Sorafenib has been recommended as first-or second-line treatment for metastatic renal cell carcinoma(mRCC)by several guidelines.The objective of this study is to evaluate the efficacy of So